Your session is about to expire
← Back to Search
Behavioral Activation for Depression
Phase 2
Recruiting
Led By Rebecca Saracino, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months post intervention
Awards & highlights
Summary
This trial tests if psychotherapy delivered by phone/video can help treat depression in older cancer survivors.
Who is the study for?
This trial is for older adults (65+) who have survived cancer, are experiencing mild to moderate depression, and can communicate via phone or video. They must be fluent in English and not require a higher level of psychiatric care. Those with major untreated psychotic disorders or recent changes in antidepressant medication use are excluded.
What is being tested?
The study tests if behavioral activation therapy, delivered remotely through telephone or videoconference, helps reduce depression in older adult cancer survivors compared to supportive psychotherapy.
What are the potential side effects?
Since the interventions involve psychological therapies rather than medications, side effects may include emotional discomfort during sessions but typically do not involve physical side effects.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months post intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months post intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Difference of Patient Health Questionnaire 9 (PHQ-9) scores between study groups
Trial Design
2Treatment groups
Experimental Treatment
Group I: Older Adult Cancer Survivors (OACS) - Supportive Psychotherapy (SP)Experimental Treatment1 Intervention
Older adult cancer survivors (OACS) will receive a Supportive Psychotherapy intervention
Group II: Older Adult Cancer Survivors (OACS) - Behavioral Activation (BA)Experimental Treatment1 Intervention
Older adult cancer survivors (OACS) will receive a Behavioral Activation intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Activation
2013
Completed Phase 3
~2940
Supportive Psychotherapy
2008
N/A
~1260
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,956 Previous Clinical Trials
595,466 Total Patients Enrolled
Rebecca Saracino, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 65 years old or older.I have difficulty making decisions due to my health condition.I have been on antidepressants for less than 3 months.I am cancer-free, or it's been 6+ months since my treatment ended.I have a history of cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Older Adult Cancer Survivors (OACS) - Supportive Psychotherapy (SP)
- Group 2: Older Adult Cancer Survivors (OACS) - Behavioral Activation (BA)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger